BEFR
US
AU
UK
KR
FR
DE
CA
JP
SE
NL
ES
NO
IT
FI
CHDE
CHFR
HR
DK
MY
OUR MISSION
As the global leader in oral appliance therapy, we set the standard for outcomes, innovation and patient experience - driving the transformation of sleep medicine worldwide
SomnoMed
Share Price
Last updated: 23/04/26 05:25:06
53¢
-0.04 (-7.02%)
Today's Open
57¢
Intraday High
57.5¢
Intraday Low
53¢
Volume
95812
About SomnoMed
We are the global leader in oral appliances for the
treatment of sleep apnea.
INVESTOR CENTRE
ASX Announcements
Notification regarding unquoted securities - SOM
20-03-2026
•
PDF
Application for quotation of securities - SOM
18-03-2026
•
PDF
Application for quotation of securities - SOM
09-03-2026
•
PDF
Notification of cessation of securities - SOM
09-03-2026
•
PDF
Investor presentation
27-02-2026
•
PDF
Half year results announcement FY26
27-02-2026
•
PDF
Half Yearly Report and Accounts
27-02-2026
•
PDF
1H FY26 Results Webinar & release date
13-02-2026
•
PDF
Application for quotation of securities - SOM
13-01-2026
•
PDF
Notification of cessation of securities - SOM
31-12-2025
•
PDF
Change of Director's Interest Notice
04-12-2025
•
PDF
Change of Director's Interest Notice
04-12-2025
•
PDF
Notification regarding unquoted securities - SOM
04-12-2025
•
PDF
Change of Director's Interest Notice
04-12-2025
•
PDF
Change of Director's Interest Notice
04-12-2025
•
PDF
Change of Director's Interest Notice
04-12-2025
•
PDF
Change of Director's Interest Notice
04-12-2025
•
PDF
Notification regarding unquoted securities - SOM
04-12-2025
•
PDF
AGM results
27-11-2025
•
PDF
AGM Investor Presentation & addresses
27-11-2025
•
PDF
Quarterly Update
30-10-2025
•
PDF
Quarterly reporting
22-10-2025
•
PDF
Canaccord Drug and Devices Conference Presentation
21-10-2025
•
PDF
Notification regarding unquoted securities - SOM
07-10-2025
•
PDF
Annual General Meeting Proxy Form
07-10-2025
•
PDF
Notice of Annual General Meeting
07-10-2025
•
PDF
Change of Director's Interest Notice
16-09-2025
•
PDF
Change in substantial holding
16-09-2025
•
PDF
Block Trade
16-09-2025
•
PDF
Corporate Governance Statement
28-08-2025
•
PDF
Appendix 4G
28-08-2025
•
PDF
Investor presentation
28-08-2025
•
PDF
Full year results announcement FY25
28-08-2025
•
PDF
Annual Report & full year results
28-08-2025
•
PDF
FY25 Financial Results release date and webinar details
07-08-2025
•
PDF
Change of Director's Interest Notice
06-08-2025
•
PDF
Change of Director's Interest Notice
06-08-2025
•
PDF
Application for quotation of securities - SOM
06-08-2025
•
PDF
Quarterly Cashflow Report
29-07-2025
•
PDF
Quarterly Activities Report
29-07-2025
•
PDF
Change of Director's Interest Notice
01-07-2025
•
PDF
Change of Director's Interest Notice
01-07-2025
•
PDF
Notification regarding unquoted securities - SOM
01-07-2025
•
PDF
Quarterly Cashflow Report
30-04-2025
•
PDF
Quarterly Activities Report
30-04-2025
•
PDF
United States of America tariff update
07-04-2025
•
PDF
Investor presentation
28-02-2025
•
PDF
FY25 Half Year Results
28-02-2025
•
PDF
Half Yearly Report and Accounts
28-02-2025
•
PDF
H1FY25 Financial Results webinar details
11-02-2025
•
PDF
Notification regarding unquoted securities - SOM
29-01-2025
•
PDF
Quarterly Appendix 4C Cash Flow Report
24-01-2025
•
PDF
FY25 Guidance Update and Quarterly Report
24-01-2025
•
PDF
Initial Director's Interest Notice
20-01-2025
•
PDF
Appointment of a Director
20-01-2025
•
PDF
Change in substantial shareholding from AEF
16-12-2024
•
PDF
Change of Director's Interest Notice
05-12-2024
•
PDF
Change of Director's Interest Notice
05-12-2024
•
PDF
Change of Director's Interest Notice
05-12-2024
•
PDF
Notification regarding unquoted securities - SOM
05-12-2024
•
PDF
AGM results
27-11-2024
•
PDF
AGM Chairman & co-CEO addresses
27-11-2024
•
PDF
Investor Presentation AGM
27-11-2024
•
PDF
FY25 Guidance Upgrade and Appointment of CFO
27-11-2024
•
PDF
Quarterly Appendix 4C Cash Flow Report
23-10-2024
•
PDF
Quarterly Activities Report
23-10-2024
•
PDF
Annual General Meeting Proxy Form
17-10-2024
•
PDF
Notice of Annual General Meeting
17-10-2024
•
PDF
Initial Director's Interest Notice
08-10-2024
•
PDF
Final Director's Interest Notice
08-10-2024
•
PDF
Rest Assure - US Food and Drug Authority (FDA) Update
07-10-2024
•
PDF
Director Appointment/Resignation
03-10-2024
•
PDF
Corporate Governance Statement
30-09-2024
•
PDF
Appendix 4G
30-09-2024
•
PDF
Annual Report to shareholders
30-09-2024
•
PDF
Change of Director's Interest Notice
23-09-2024
•
PDF
Change of Director's Interest Notice
09-09-2024
•
PDF
Investor Presentation
28-08-2024
•
PDF
FY24 Preliminary Report and FY25 Guidance
28-08-2024
•
PDF
Preliminary Final Report
28-08-2024
•
PDF
FY24 full year results investor conference call details
21-08-2024
•
PDF
Quarterly Cashflow Report
24-07-2024
•
PDF
Quarterly Activities Report
24-07-2024
•
PDF
Change of Director's Interest Notice
01-07-2024
•
PDF
Change of Director's Interest Notice
01-07-2024
•
PDF
Notification regarding unquoted securities - SOM
01-07-2024
•
PDF
Notification regarding unquoted securities - SOM
28-06-2024
•
PDF
Results of Meeting
27-06-2024
•
PDF
Proxy Form
20-05-2024
•
PDF
Notice of Extraordinary General Meeting
20-05-2024
•
PDF
Repayment of Epsilon facility
13-05-2024
•
PDF
Change in substantial shareholding from AEF
10-05-2024
•
PDF
Change in substantial holding
10-05-2024
•
PDF
Change of Director's Interest Notice
09-05-2024
•
PDF
Change of Director's Interest Notice
08-05-2024
•
PDF
Change of Director's Interest Notice
08-05-2024
•
PDF
Change of Director's Interest Notice
08-05-2024
•
PDF
Change of Director's Interest Notice
08-05-2024
•
PDF
Change in substantial holding
08-05-2024
•
PDF
Application for quotation of securities - SOM
08-05-2024
•
PDF
Completion of retail component of Entitlement Offer
03-05-2024
•
PDF
Notification of cessation of securities - SOM
01-05-2024
•
PDF
Quarterly Activities Report
29-04-2024
•
PDF
Quarterly Cashflow Report
29-04-2024
•
PDF
Change in substantial holding
18-04-2024
•
PDF
Change in substantial shareholding from AEF
18-04-2024
•
PDF
Application for quotation of securities - SOM
16-04-2024
•
PDF
Dispatch of Entitlement Offer documents
16-04-2024
•
PDF
Replacement Prospectus
16-04-2024
•
PDF
Reinstatement to Quotation
10-04-2024
•
PDF
Completion of institutional component of Entitlement Offer
10-04-2024
•
PDF
Proposed issue of securities - SOM
09-04-2024
•
PDF
Investor Presentation
09-04-2024
•
PDF
Prospectus Entitlement Offer
09-04-2024
•
PDF
Revised guidance and capital raising
09-04-2024
•
PDF
Update on voluntary suspension & FY24 earnings guidance
05-04-2024
•
PDF
Suspension from Quotation
02-04-2024
•
PDF
Trading Halt
27-03-2024
•
PDF
Investor presentation
28-02-2024
•
PDF
Solid start in 1H as core business revenues increase 13%
28-02-2024
•
PDF
Half Yearly Report and Accounts
28-02-2024
•
PDF
Change of Director's Interest Notice
23-02-2024
•
PDF
Change of Director's Interest Notice
23-02-2024
•
PDF
Notification of cessation of securities - SOM
22-02-2024
•
PDF
Final Director's Interest Notice
22-02-2024
•
PDF
Material terms of employment agreements Co-CEO's
22-02-2024
•
PDF
Appointment of Co-CEO's
22-02-2024
•
PDF
Quarterly Appendix 4C Cash Flow Report
30-01-2024
•
PDF
Quarterly Activities Report
30-01-2024
•
PDF
Ceasing to be a substantial holder
28-12-2023
•
PDF
Results of Meeting
24-11-2023
•
PDF
AGM presentation
24-11-2023
•
PDF
AGM Chairman & CEO addresses
24-11-2023
•
PDF
Quarterly Activities Report
30-10-2023
•
PDF
Quarterly cash report
30-10-2023
•
PDF
Wilson's conference- presentation
26-10-2023
•
PDF
Proxy Form AGM
24-10-2023
•
PDF
Notice of Annual General Meeting
24-10-2023
•
PDF
Notification of cessation of securities - SOM
12-10-2023
•
PDF
Final Director's Interest Notice
12-10-2023
•
PDF
Director resignation
12-10-2023
•
PDF
Change in Substantial Shareholding from AEF
03-10-2023
•
PDF
Annual Report to shareholders- correction
28-09-2023
•
PDF
Corporate Governance Statement
28-09-2023
•
PDF
Appendix 4G
28-09-2023
•
PDF
Annual Report to shareholders
28-09-2023
•
PDF
Change of Director's Interest Notice
28-09-2023
•
PDF
Change of Director's Interest Notice
28-09-2023
•
PDF
Change of Director's Interest Notice
28-09-2023
•
PDF
Change of Director's Interest Notice
28-09-2023
•
PDF
Change of Director's Interest Notice
28-09-2023
•
PDF
Change of Director's Interest Notice
28-09-2023
•
PDF
Change in substantial holding
28-09-2023
•
PDF
Application for quotation of securities - SOM
27-09-2023
•
PDF
Results of Retail Entitlement Offer
26-09-2023
•
PDF
Change of Director's Interest Notice
13-09-2023
•
PDF
Change of Director's Interest Notice
13-09-2023
•
PDF
Change in substantial holding
12-09-2023
•
PDF
Change in substantial holding
12-09-2023
•
PDF
Change in Substantial Shareholding from AEF
12-09-2023
•
PDF
Change in substantial holding
11-09-2023
•
PDF
Change in Substantial Shareholding from AEF
11-09-2023
•
PDF
Cleansing Notice
08-09-2023
•
PDF
Dispatch Retail Entitlement Offer Booklet
07-09-2023
•
PDF
Application for quotation of securities - SOM
07-09-2023
•
PDF
Notification to ineligible shareholders
07-09-2023
•
PDF
Retail Entitlement Offer Booklet
07-09-2023
•
PDF
Successful completion of institutional Offer and Placement
04-09-2023
•
PDF
Cleansing Notice
31-08-2023
•
PDF
Proposed issue of securities - SOM
31-08-2023
•
PDF
Investor presentation
31-08-2023
•
PDF
FY23 results and Capital raising
31-08-2023
•
PDF
Preliminary Final Report
31-08-2023
•
PDF
Trading Halt
31-08-2023
•
PDF
FY23 full year results conference call- change of date
28-08-2023
•
PDF
FY23 full year results conference call- change of date
18-08-2023
•
PDF
FY23 full year results investor conference call details
14-08-2023
•
PDF
Notification of cessation of securities - SOM
31-07-2023
•
PDF
Quarterly Activities Report
26-07-2023
•
PDF
Appendix 4C
26-07-2023
•
PDF
New CFO Appointment
05-07-2023
•
PDF
Quarterly Activities Report
04-05-2023
•
PDF
Appendix 4C - March 2023
28-04-2023
•
PDF
Growth momentum maintained
28-04-2023
•
PDF
Change of Director's Interest Notice
01-03-2023
•
PDF
Investor Presentation
22-02-2023
•
PDF
Revenue growth momentum continues in 1H FY23
22-02-2023
•
PDF
Half Yearly Report and Accounts
22-02-2023
•
PDF
Updated Quarterly Activities
01-02-2023
•
PDF
Appendix 4C - December 2022
30-01-2023
•
PDF
Second quarter revenue growth of 17% to $21.4 million
30-01-2023
•
PDF
Results of Meeting
25-11-2022
•
PDF
AGM Chairman and CEO addresses
25-11-2022
•
PDF
AGM Investor Presentation
25-11-2022
•
PDF
Change of Registry Address
31-10-2022
•
PDF
Appendix 4C....typographical correction
26-10-2022
•
PDF
AGM Proxy
25-10-2022
•
PDF
Notice of AGM
25-10-2022
•
PDF
Appendix 4C Cash Flow Report
25-10-2022
•
PDF
North America Q1 revenue growth leads the way
25-10-2022
•
PDF
Change in substantial holding
04-10-2022
•
PDF
Change of Director's Interest Notice
30-09-2022
•
PDF
Corporate Governance Statement
27-09-2022
•
PDF
Appendix 4G
27-09-2022
•
PDF
Annual Report to shareholders
27-09-2022
•
PDF
Investor presentation
23-08-2022
•
PDF
FY22 results and FY23 guidance
23-08-2022
•
PDF
Preliminary Final Report
23-08-2022
•
PDF
FY22 Full year financial results investor conference call
08-08-2022
•
PDF
Quarterly Cash Flow Report
26-07-2022
•
PDF
Record Q4 and delivers on FY22 revenue guidance
26-07-2022
•
PDF
Change in substantial holding from AEF
31-05-2022
•
PDF
Quarterly Appendix 4C Cash Flow Report
27-04-2022
•
PDF
Strong revenue growth and continued positive momentum
27-04-2022
•
PDF
Change of Director's Interest Notice
18-03-2022
•
PDF
SomnoMed introduces Rest Assure
22-02-2022
•
PDF
Investor Presentation
22-02-2022
•
PDF
Revenues on track despite COVID-19 disruptions
22-02-2022
•
PDF
Half Yearly Report and Accounts
22-02-2022
•
PDF
Half-year financial results Investor conference call details
14-02-2022
•
PDF
World first technology enabled oral appliance
31-01-2022
•
PDF
Appendix 4C Cash Flow Report
27-01-2022
•
PDF
North America Q2 revenue 36% amid regional variability
27-01-2022
•
PDF
Half Yearly Report and Accounts 27 Feb 2026
27-02-2026
•
PDF
2025 Annual Report
AGM 2025
27-11-2025
•
PDF
Investor Presentation 2025
28-08-2025
•
PDF
Quarterly Cash Flow Report June 2025
29-07-2025
•
PDF
Quarterly Activities Report 30 June 2025
29-07-2025
•
PDF
Quarterly Activities Report March 2025
30-04-2025
•
PDF
Quarterly Cash Flow Report March 2025
30-04-2025
•
PDF
Half Yearly Report and Accounts
28-02-2025
•
PDF
FY25 Half Year Results
28-02-2025
•
PDF
Investor Presentation Feb 2025
28-02-2025
•
PDF
Quarterly Appendix 4C Cash Flow Report
24-01-2025
•
PDF
FY25 Guidance Update and Quarterly Report
24-01-2025
•
PDF
2024 Annual Report
SOM Investor Presentation 1H24-final
08-08-2024
•
PDF
FY24 Preliminary Report and FY25 Guidance
28-08-2024
•
PDF
Preliminary Final Report
28-08-2024
•
PDF
Quarterly Cashflow Report
24-07-2024
•
PDF
Quarterly activities report
24-07-2024
•
PDF
Quarterly Activities Report
29-04-2024
•
PDF
Quarterly Cash flow report
29-04-2024
•
PDF
Investor Presentation
09-04-2024
•
PDF
2023 Annual Report
SomnoMed Wilsons Conference October 2023
31-10-2023
•
PDF
SOM-AGM-Presentation-2023
06-09-2023
•
PDF
SOM - FY23 Results and Capital Raising Presentation (Final)
03-09-2023
•
PDF
SOM-Investor-Presentation-22.2.23
22-02-2023
•
PDF
2022 Annual Report
SOM-Investor-Presentation-FY22-FINAL-compressed
30-09-2022
•
PDF
SOM-Results-Presentation-1H22
30-03-2022
•
PDF
2021 Annual Report
2020 Annual Report
2019 Annual Report
2018 Annual Report
2017 Annual Report
2016 Annual Report
2015 Annual Report
2014 Annual Report
2013 Annual Report
2012 Annual Report
Taylor Collison, Morgans and Wilsons Advisory provide coverage of SomnoMed, and regularly update their reports.
Used to load accordion assets. don’t remove.
SHAREHOLDER
Contacts
Contact Investor Relations
Have a question for SomnoMed? Send us an email at the address below and our team will be in contact shortly.
Shareholder Services
Shareholders can access information such as holding balance, change of address, and annual report preferences by contacting Boardroom Pty Ltd using the form below:
Oops! We could not locate your form.